Accumetrics, Inc. San Diego, CA
Accumetrics develops, manufactures, and markets the VerifyNow System for the assessment of platelet function in patients taking powerful platelet antiplatelet therapies such as Aspirin, Plavix, and IIb/IIIa inhibitors.

 
 
Auxeris Therapeutics, Inc. St. Louis, MO
Biopharmaceutical company developing proprietary breakthrough medications to treat a broad range of bone diseases.

 
 
CGI Pharmaceuticals, Inc. Branford, CT
CGI Pharmaceuticals, Inc. is developing breakthrough therapeutics for cancer and autoimmune diseases using proprietary kinase-inhibitor drug discovery and development tools.

 
 
Cabrellis Pharmaceuticals Corporation San Diego, CA
Acquired by Pharmion Corporation (PHRM)
A specialty pharmaceutical company committed to the development of important therapies for the treatment of cancer.


 
 
Calypso Medical Technologies, Inc. Seattle, WA
Medical device company developing novel implantable sensors for localizing external beam radiation therapy and surgical treatments in oncology.

 
 
Cameron Health, Inc. San Clemente, CA
A medical device company that has created a next generation implantable defibrillator that is easier to implant and does not require leads that attach to the heart.

 
 
Centerre Healthcare Corporation St. Louis, MO
Healthcare services company providing inpatient rehabilitation services through hospital-within-a-hospital and joint venture facilities.

 
 
Conforma Therapeutics Corporation San Diego, CA
Acquired by Biogen Idec (BIIB)
Biotechnology company developing drugs that target a novel pathway, HSP90 inhibition, for the treatment of cancer.


 
 
CyDex, Inc. Overland, KS
Drug formulation and development company commercializing a proprietary technology that improves drug solubility.

 
 
Excaliard Pharmaceuticals, Inc. Encinitas, CA
Biopharmaceutical company focused on developing drugs for the local treatment of fibrosis, including skin scarring.

 
 
IDev Technologies, Inc. Houston, TX
Medical device company developing a novel stent for the treatment of peripheral vascular disease.

 
 
Kereos, Inc. St. Louis, MO
Biotechnology company developing site-targeted drugs and molecular imaging agents for cancer and cardiovascular disease.

 
 
Luminous Medical, Inc. Carlsbad, CA
Luminous Medical is developing an automated glucose measurement system to facilitate tight glycemic control in hospital intensive care units.

 
 
Lutonix, Inc. Minneapolis, MN
Medical device company developing cardiovascular related products.

 
 
Macrogenics, Inc. Rockville, MD
A leading antibody therapeutics company with a focus on autoimmune diseases and cancer.

 
 
NexRay, Inc. Los Gatos, CA
Medical device company developing a low-dose, scanning x-ray fluoroscopy system for interventional cardiology.

 
 
Salient Surgical Technologies (formerly TissueLink Medical) Dover, NH
Medical device company commercializing innovative radio-frequency electrosurgical instruments for orthopedics and general surgery.

 
 
Tryton Medical, Inc. Newton, MA
Tryton Medical, Inc. is developing stents that are designed to treat bifurcation lesions.

 
 
Velocimed, LLC Minneapolis, MN
Acquired by St. Jude Medical, Inc. (STJ)
Leading edge medical technology company developing endovascular and cardiology-related medical devices.


 
 
Xcyte Therapies, Inc. Seattle, WA
NASDAQ: XCYT, Acquired by Cyclacel Pharmaceuticals (CYCC)
Biotechnology company developing novel cell-based immunotherapeutic treatments for cancer and infectious disease.


 
 
Xoft, Inc. Fremont, CA
Medical device company that has developed electronic, miniaturized x-ray technology for use in radiation oncology.


©2005 RiverVest Venture Management, LLC

Home